Your Article Summary
Boston Scientific to Participate in Wachovia Conference
Boston Scientific, 06/19/09
Boston Scientific Corporation is scheduled to participate in the Wachovia 19th Annual Mid-Year Equity Conference, June.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
SAR3419 Phase I Study Results in non-Hodgkins Lymphoma at ASH
ImmunoGen, Inc., 12/07/09
Allos Therapeutics' FOLOTYN Demonstrates Activity in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Treated with Stem Cell Transplant
Allos Therapeutics, 12/07/09
Allos Therapeutics Reports New Analyses of Data from Pivotal PROPEL Trial of FOLOTYN at 51st ASH Annual Meeting
Allos Therapeutics, 12/07/09
Article Search
Sponsor


See Latest Articles


